-+ 0.00%
-+ 0.00%
-+ 0.00%
Insight Molecular Diagnostics: Q3 Earnings Snapshot
Share
Listen to the news

NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $3.6 million in its third quarter.

On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 10 cents. Losses, adjusted for non-recurring gains, came to 19 cents per share.

The cancer diagnostic test developer posted revenue of $559,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMDX at https://www.zacks.com/ap/IMDX

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending